What is TTRX's operating income?

TTRX (TTRX) reported operating income of -$1.25M in Q1 2026.

How has TTRX's operating income changed year-over-year?

TTRX's operating income decreased by 223.7% year-over-year, from -$385K to -$1.25M.

What does operating income mean?

Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.

TTRX TTRX Operating Income

Operating Income at other companies

Regeneron PharmaceuticalsREGN

$642.9M+8.7%

Bausch Health CompaniesBHC

-$950M-444%

Journey Medical CorporationDERM

-$1.49M+55.1%

PTH

Pelthos Therapeutics Inc.PTHS

-$13.09M-614%

Celldex TherapeuticsCLDX

-$84.44M-34.6%

Arcutis Biotherapeutics, Inc.ARQT

-$9.09M+62.9%

Other financials

Income statement

See full

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Enterprise value$212.24M—

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Reported directly by TTRX in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's operating income?: TTRX (TTRX) reported operating income of -$1.25M in Q1 2026.
How has TTRX's operating income changed year-over-year?: TTRX's operating income decreased by 223.7% year-over-year, from -$385K to -$1.25M.
What does operating income mean?: Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.